All lobbying filings

CME GROUP, INC.

CME GROUP, INC. filed a Q1 report for CME GROUP INC on April 16, 2025.

Lobbying for CME GROUP INC

All filings by CME GROUP, INC. · Everything CME GROUP INC has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 16, 2025

Expenses

$430,000

What this organization spent lobbying with its own staff. Reported using IRS section 162(e) definitions (method C): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Agriculture

Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) (Title VII: Wall Street Transparency and Accountability); Issues related to regulation of clearinghouses, swap data repositories, swap execution facilities, and designated contract markets; Issues related to CFTC Funding; Issues related to Derivatives Clearing Market Structure; Issues related to CFTC Reauthorization; H.R. 4763 - Financial Innovation and Technology for the 21st Century Act (118th Congress) (issues related to Sec. 101 - Definitions under the Securities Act of 1933, Sec. 102 - Definitions under the Commodity Exchange Act, Sec. 103 - Definitions under this Act, Sec. 107 - Commodity Exchange Act savings provisions, and Section 401 - Commission jurisdiction over digital commodity transactions); Issues related to the Clearing of US Treasury futures.

Financial Institutions/Investments/Securities

Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) (Title II: Issues related to orderly liquidation authority and Title VIII: Payment Clearing and Settlement Supervision); Issues related to the regulation of systemically important financial market utilities; Issues related to Crypto Spot Market Regulation; S. 394 - GENIUS Act of 2025; H.R. 2392 - STABLE Act of 2025; Issues related to Basel III Bank Capital Standards; Issues related to the Clearing of US Treasury futures.

Taxation/Internal Revenue Code

Issues related to tax treatment of futures, securities, and commodities; Issues related to Sec. 1256 of the tax code related to the tax treatment of futures and options.

Bills named in this filing 3

H.R. 4763
Financial Innovation and Technology for the 21st Century Act
S. 394
GENIUS Act of 2025
H.R. 2392
STABLE Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.